Luts & Greenleigh Group Inc. trimmed its position in AbbVie Inc. ( NYSE:ABBV – Free Report ) by 0.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,614 shares of the company's stock after selling 88 shares during the quarter. AbbVie makes up approximately 2.3% of Luts & Greenleigh Group Inc.'s portfolio, making the stock its 5th largest position. Luts & Greenleigh Group Inc.'s holdings in AbbVie were worth $1,834,000 at the end of the most recent reporting period.

https://www.dailypolitical.com/2023/09/26/abbvie-inc-nyseabbv-shares-sold-by-luts-greenleigh-group-inc.html

#dailypolitical